当前位置:首页 - 行情中心 - 北大医药(000788) - 财务分析 - 现金流量表

北大医药

(000788)

  

流通市值:32.06亿  总市值:32.06亿
流通股本:5.96亿   总股本:5.96亿

现金流量表

报告期2026-06-302026-03-312025-12-312025-09-30
公司类型通用通用通用通用
一、经营活动产生的现金流量:
  销售商品、提供劳务收到的现金676,537,071.57451,230,437.122,098,209,170.911,517,794,528.27
  收到的税费返还--3,022,725.02-
  收到其他与经营活动有关的现金28,032,475.775,554,402.1727,450,446.9823,848,600.04
  经营活动现金流入小计704,569,547.34456,784,839.292,128,682,342.911,541,643,128.31
  购买商品、接受劳务支付的现金235,123,909.55123,219,254.811,229,401,067.791,007,156,034.89
  支付给职工以及为职工支付的现金95,917,227.761,105,952.06172,250,303.23133,109,214.66
  支付的各项税费35,598,795.4815,068,149.04111,821,00287,176,115.69
  支付其他与经营活动有关的现金95,575,656.2969,937,868.74227,918,412.6182,463,406.85
  经营活动现金流出小计462,215,589.02269,331,224.651,741,390,785.621,409,904,772.09
  经营活动产生的现金流量净额242,353,958.32187,453,614.64387,291,557.29131,738,356.22
二、投资活动产生的现金流量:
  收回投资收到的现金165,282,462.5590,524,102.8195,866,107.7653,153,941.04
  取得投资收益收到的现金-2,114,170.02-4,170,892.56
  处置固定资产、无形资产和其他长期资产收回的现金净额162,560162,480151,884.6466,897.38
  收到的其他与投资活动有关的现金-721.78--
  投资活动现金流入小计165,445,022.5592,801,474.6196,017,992.457,391,730.98
  购建固定资产、无形资产和其他长期资产支付的现金5,794,059.312,809,847.1848,766,517.8329,837,826.87
  投资支付的现金376,051,032.92134,084,842.68395,392,808.3977,961,305.59
  投资活动现金流出小计381,845,092.23136,894,689.86444,159,326.22107,799,132.46
  投资活动产生的现金流量净额-216,400,069.68-44,093,215.25-348,141,333.82-50,407,401.48
三、筹资活动产生的现金流量:
  收到其他与筹资活动有关的现金--5,942,460.44-
  筹资活动现金流入平衡项目--0-
  筹资活动现金流入小计--5,942,460.44-
  偿还债务支付的现金--30,000,000-
  分配股利、利润或偿付利息支付的现金100,125,887.4100,125,887.436,565,245.5130,383,546.12
  支付其他与筹资活动有关的现金17,286,417.9614,948,254.4519,819,417.7215,299,278.15
  筹资活动现金流出小计117,412,305.36115,074,141.8586,384,663.2345,682,824.27
  筹资活动产生的现金流量净额-117,412,305.36-115,074,141.85-80,442,202.79-45,682,824.27
五、现金及现金等价物净增加额-91,458,416.7228,286,257.54-41,291,979.3235,648,130.47
  加:期初现金及现金等价物余额545,138,690.34545,138,690.34586,430,669.66586,430,669.66
  期末现金及现金等价物余额453,680,273.62573,424,947.88545,138,690.34622,078,800.13
补充资料:
  净利润55,670,813.75-82,882,957.79-
  资产减值准备20,180,660.93-26,449,796.67-
  固定资产和投资性房地产折旧8,320,628.44-16,077,156.31-
  其中:固定资产折旧、油气资产折耗、生产性生物资产折旧8,320,628.44-16,077,156.31-
  无形资产摊销6,404,261.36-15,601,533.78-
  长期待摊费用摊销37,627.14-12,542.38-
  处置固定资产、无形资产和其他长期资产的损失24,269.75--29,633.81-
  固定资产报废损失-25,827.93--10,676.86-
  公允价值变动损失-40,445.07---
  财务费用-1,366,221.55-1,693,001.2-
  投资损失-14,363,271.73--6,958,543.26-
  递延所得税7,615,152.66--5,858,741.86-
  其中:递延所得税资产减少7,632,394.78--5,875,983.98-
    递延所得税负债增加-17,242.12-17,242.12-
  存货的减少13,505,802.68-49,694,012.2-
  经营性应收项目的减少178,163,574.25-533,937,051.37-
  经营性应付项目的增加-41,791,393.06--348,960,905.14-
  不涉及现金收支的投资和筹资活动金额其他项目--11,393,296.38-
  现金的期末余额453,680,273.62-545,138,690.34-
  减:现金的期初余额545,138,690.34-586,430,669.66-
  现金及现金等价物的净增加额-91,458,416.72--41,291,979.32-
公告日期2026-08-252026-04-282026-04-282025-10-31
审计意见(境内)标准无保留意见
TOP↑